| Identification of accurate biomarkers to better select appropriate phenotypes is essential to evaluate new drug candidates for the adjunctive treatment of sepsis |
| More than 10 promising drugs are currently in clinical development in the sepsis field |
| Immune response is probably one of the most appropriate targets to work on |
| Several drugs, including monoclonal antibodies, are likely to be marketed in a near future |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.